CartiJoint™ FORTE is the First Product in Fidia’s New Dietary
Supplement Portfolio; Uniquely formulated with bioactive Bio-Curcumin
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Fidia, a world leader in the research, development, and manufacturing of
hyaluronic acid (HA)-based products, is introducing CartiJoint™ FORTE,
its first product in the dietary supplement category in the USA.
CartiJoint™ FORTE is a dietary supplement that supports joint health and
mobility with antioxidant activity in a daily dose.*1,2,3 It
is uniquely formulated with a bioactive* curcumin extract Bio-Curcumin
Curcugreen™ which is 100% natural turmeric along with glucosamine
hydrochloride and chondroitin sulfate.
Bio-Curcumin Curcugreen™ is from a natural substance with antioxidant
activity*. It is a natural extract of Curcuma longa consisting of
curcumin, curcuminoids, and oils with high bioavailability compared with
standard curcumin and another formula containing curcumin in a pilot
study of human volunteers receiving equivalent doses.4
CartiJoint™ FORTE also contains glucosamine hydrochloride and
chondroitin sulfate. In the human joint, naturally occurring glucosamine
and chondroitin are important structural components that provide support
and promote joint mobility and flexibility. Chondroitin sulfate is also
an important structural component of cartilage.
“The introduction of CartiJoint™ FORTE is the first product in the new
Fidia Dietary Supplement Portfolio and reinforces our vision for Fidia’s
growth in the U.S.,” said Giorgio Masetti, president at Fidia Pharma USA
Inc. “Supported by over 50 years of research, Fidia’s aim is to continue
to bring new top-quality products to the U.S. market, expand our product
lines and evolve by diversifying into new, emerging product categories
that are in line with our mission of innovating and pioneering new
solutions to help people move forward through life. We are excited to
offer more options than ever to patients seeking non-surgical solutions
with our convenient, non-surgical quality products.”
CartiJoint™ FORTE is available in a convenient blister pack over the
counter and may be purchased online at www.cartijoint.com.
Further information can be found at www.cartijoint.com
and at the Fidia Pharma USA Inc. Booth #511 at the AMSSM (American
Medical Society for Sports Medicine) Annual Meeting, April 12-17, in
* These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, cure, or
About Fidia Pharma USA Inc.
Fidia Pharma USA Inc. is a wholly-owned subsidiary of Italian
pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established
leader in the hyaluronic acid market segment.
Fidia Pharma USA Inc. is focused on expanding Fidia’s position in the
U.S. and Canadian market, while upholding the company’s mission to
provide consumers with innovative products that offer quality, safety,
and performance. Fidia Pharma USA Inc. is headquartered in Florham Park,
For more information, please visit www.fidiapharma.us.
1. Lippiello L et al., Clin Orthop Relat Res 2000; 381: 229-40 2. Das A
Jr, Hammad TA, Osteoarthritis Cartilage 2000; 8:343-50 3. Chainani-Wu N,
Altern J, Compl Med 2003; 9(1): 161-68 4. Antony B, Merina B, Iyer VS,
Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human
oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced
preparation of curcumin. Indian J Pharm Sci 2008; 70:445-449
Distributed in the USA by FIDIA PHARMA USA INC. CartiJoint™ FORTE is a
trademark of FIDIA FARMACEUTICI S.P.A., Abano Terme (PD), Italy.
Curcugreen™ is a trademark of Arjuna Natural Extracts Ltd. ©2019 FIDIA
PHARMA USA INC., Florham Park, NJ 07932 FID-738-04-2019
FIDIA PHARMA USA INC.